MEIP icon

MEI Pharma
MEIP

Overview Fund Activity

31 hedge funds and large institutions have $5.85M invested in MEI Pharma in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-1
Holders Change %
-3.13%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
9
Closed
2
Calls
$28K
Puts
$1K
Net Calls
+$27K
Net Calls Change
+$57K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
$881K
2
Citadel Advisors
Citadel Advisors
Florida
$81.4K
3
GIA
GHP Investment Advisors
Colorado
$329
4
TRCT
Tower Research Capital (TRC)
New York
$3.43K
5
Wells Fargo
Wells Fargo
California
$110

Top Sellers

1
Northern Trust
Northern Trust
Illinois
$23.1K
2
VF
Virtu Financial
New York
$0
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
$209K
4
UBS Group
UBS Group
Switzerland
$14.1K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$41.8K
Name Holding Trade Value Shares
Change 		Shares
Change %
EWM
26
Evermay Wealth Management
Virginia
$276 – – –
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
$178 -$4 -2 -2%
T
28
Transce3nd
Texas
$175 – – –
MCM
29
MAI Capital Management
Ohio
$165 – – –
Wells Fargo
30
Wells Fargo
California
$110 +$55 +25 +100%
VF
31
Virtu Financial
New York
– -$26K -10,744 Closed
Fidelity Investments
32
Fidelity Investments
Massachusetts
– -$5 -2 Closed
1
2